Kercia Cruz | Agricultural and Biological Sciences | Best Researcher Award

Dr. Kercia Cruz | Agricultural and Biological Sciences | Best Researcher Award

Federal University of Bahia | Brazil

Author Profile

Orcid

Early Academic Pursuits 🎓

Dr. Kercia Cruz began her academic journey with a degree in Biological Sciences from Universidade Federal da Bahia in 2014. She furthered her studies with a master’s in Biotechnology in Health and Investigative Medicine from Fundação Oswaldo Cruz, graduating in 2017. Her research during this period focused on leishmaniasis and the role of macrophages in infection. She then pursued a Ph.D. in Biotechnology in Health and Investigative Medicine at Fundação Oswaldo Cruz, completing it in 2023. Her doctoral research centered on the development of nanomedicines for treating leishmaniasis, particularly focusing on the protein translocator HSP90.

Professional Endeavors 🔬

Dr. Cruz has worked extensively in the field of general biology with a specialization in leishmaniasis and macrophage infections. Her professional experience includes positions at Universidade Federal da Bahia and Centro Universitário SENAI CIMATEC, where she has contributed significantly to research and education. Her roles involved working on projects related to the therapeutic potential of nanoparticles and the molecular mechanisms of leishmaniasis. She has also participated in various internships and short-term research activities across Brazil and Portugal. 🌍

Contributions and Research Focus 🧫

Dr. Cruz’s research primarily focuses on leishmaniasis, particularly the use of nanomedicines and the role of protein translocators like HSP90 in combating infection. She has been involved in several research projects exploring the potential of nanoparticle-based therapies for leishmaniasis and other infectious diseases. Her work also includes studying the molecular and cellular aspects of macrophage interactions with pathogens, contributing to the development of innovative treatment strategies. 🧪

Accolades and Recognition 🏅

Dr. Cruz has received notable recognition for her research contributions. In 2022, she was awarded an honorable mention for her work on polymeric nanoparticles containing amphotericin B at Embrapa. Additionally, she received a commendation in 2020 for her ongoing doctoral thesis from the Program of Postgraduate Studies in Biotechnology in Health and Investigative Medicine at Fiocruz. These accolades highlight her significant impact in her field. 🏆

Impact and Influence 🌟

Dr. Cruz’s research has advanced the understanding of leishmaniasis and the potential of nanomedicines in treating this disease. Her work on nanomedicine and protein translocators has provided valuable insights into innovative treatment approaches, potentially improving patient outcomes and contributing to global health solutions. Her contributions have influenced both academic research and practical applications in biotechnology. 🌐

Legacy and Future Contributions 🚀

Looking forward, Dr. Cruz aims to continue her work on developing novel therapeutic strategies for infectious diseases. Her future research will likely focus on expanding the use of nanomedicines and exploring new avenues in molecular biology to address pressing health challenges. Her dedication to advancing scientific knowledge and improving treatment options ensures that her legacy will continue to benefit the field of biotechnology and beyond.

 

Publications 📚


  • 📝Intraperitoneal Administration of 17-DMAG as an Effective Treatment against Leishmania braziliensis Infection in BALB/c Mice: A Preclinical Study
    • Authors: Kercia P. Cruz, Antonio L. O. A. Petersen, Marina F. Amorim, Alan G. S. F. Pinho, Luana C. Palma, Diana A. S. Dantas, Mariana R. G. Silveira, Carine S. A. Silva, Ana Luiza J. Cordeiro, Izabella G. Oliveira, Gabriella B. Pita, Bianca C. A. Souza, Gilberto C. Bomfim, Cláudia I. Brodskyn, Deborah B. M. Fraga, Isadora S. Lima, Maria B. R. De_Santana, Helena M. P. Teixeira, Juliana P. B. De_Menezes, Washington L. C. Santos
    • Journal: Pathogens
    • Year: 2024

  • 📝Development and Characterization of PLGA Nanoparticles Containing 17-DMAG, an Hsp90 Inhibitor
    • Authors: Kercia P. Cruz, Beatriz F. C. Patricio, Vinícius C. Pires, Marina F. Amorim, Alan G. S. F. Pinho, Helenita C. Quadros, Diana A. S. Dantas, Marcelo H. C. Chaves, Fabio R. Formiga, Helvécio V. A. Rocha, Patrícia S. T. Veras
    • Journal: Frontiers in Chemistry
    • Year: 2021

  • 📝Microbiologia no cotidiano: proposta de ensino por investigação de baixo custo
    • Authors: K. P. Cruz, G. L. Nery, A. A. D. Reboucás, P. R. Dantas-Silva, J. S. Cruz, C. G. S. Andrade, R. M. L. Rahimy
    • Journal: Atas de Ciências da Saúde
    • Year: 2019

  • 📝In vitro evaluation of the anti-leishmanial activity and toxicity of PK11195
    • Authors: C. E. S. Guedes, B. R. S. Dias, A. L. O. A. Petersen, Kercia P. Cruz, N. J. Almeida, D. R. Andrade, J. P. B. Menezes, V. M. Borges, P. S. T. Veras
    • Journal: Memórias do Instituto Oswaldo Cruz
    • Year: 2018